| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/11/2004 | WO2003014316A3 Immunomodulatory compositions, formulations, and methods for use thereof |
| 03/11/2004 | WO2003000185A3 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 03/11/2004 | WO2002096349A3 Vaccination against the feline immunodeficiency virus |
| 03/11/2004 | WO2002083709A3 Kinases and phosphatases |
| 03/11/2004 | WO2002079441A3 Secreted proteins |
| 03/11/2004 | WO2002076404A3 Fatty alcohol drug conjugates |
| 03/11/2004 | US20040049045 Process for the crystallization of (r)-or (s)-lansoprazole |
| 03/11/2004 | US20040049018 For inhibiting HIV virus |
| 03/11/2004 | US20040049016 The glycoproteins induce apoptosis and can be used as a therapeutic agent against Flavivirus infection and cancer |
| 03/11/2004 | US20040049011 Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome |
| 03/11/2004 | US20040048917 New use of compounds as antibacterial agents |
| 03/11/2004 | US20040048907 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 03/11/2004 | US20040048903 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes |
| 03/11/2004 | US20040048898 Benzimidazole compound crystal |
| 03/11/2004 | US20040048897 Il-8 receptor antagonists |
| 03/11/2004 | US20040048882 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted |
| 03/11/2004 | US20040048859 Substituted glutarimides and their use as inhibitors of IL-12 production |
| 03/11/2004 | US20040048857 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions. |
| 03/11/2004 | US20040048855 Inhibitors of interleukin 1-beta converting enzyme |
| 03/11/2004 | US20040048853 Compounds, compositions, and methods |
| 03/11/2004 | US20040048849 Cyclin-dependent kinase (cdk) and glycolene synthase kinase-3 (gsk-3) inhibitors |
| 03/11/2004 | US20040048835 7-Substituted fused ring tetracycline compounds |
| 03/11/2004 | US20040048801 Use of activity-dependent neurotrophic factor-derived polypeptides for enhancing learning and memory:pre-and post-natal administration |
| 03/11/2004 | US20040048795 Stimulating a vagus nerve pathway in the brain; inhibiting apoptosis of a cardiac myocyte |
| 03/11/2004 | US20040048774 Inhibitors of IMPDH enzyme |
| 03/11/2004 | US20040048353 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 03/11/2004 | US20040048338 IL-17 receptor like molecules and uses thereof |
| 03/11/2004 | US20040048325 Glycosyltransferase inhibitors |
| 03/11/2004 | US20040048294 Diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins |
| 03/11/2004 | US20040048256 Isolated polypeptide of given sequence; use in screening for identifying therapeutic antibodies and drugs |
| 03/11/2004 | US20040047903 For use in therapy of cancer |
| 03/11/2004 | US20040047894 Preparation for improved dietary utilisation |
| 03/11/2004 | US20040047885 Use of compounds which make it possible to modify the physicochemical properties of the skin and/or the mucous membranes as agents preventing or reducing the adhesion of microorganisms to the latter |
| 03/11/2004 | US20040047882 Use of an oil-in-water emulsion as adjuvant for vaccines to be applied contralaterally, the emulsion comprising approx. 5% squalene, 0.5% polysorbate 80 and 0.5% sorbitan trioleate in aqueous citrate buffer pH 6.5 |
| 03/11/2004 | US20040047881 Delivery of disease control in aquaculture and agriculture using microbes containing bioactive proteins |
| 03/11/2004 | US20040047880 Component for vaccine |
| 03/11/2004 | US20040047879 Vaccine for treating hepatitis B and primary hepatocellular carcinoma |
| 03/11/2004 | US20040047878 DNA vaccine against feline immunodeficiency virus |
| 03/11/2004 | US20040047877 Immunodominant human T-cell epitopes of hepatitis C virus |
| 03/11/2004 | US20040047876 Compositions and methods for the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress proteins |
| 03/11/2004 | US20040047871 For conferring protective immunity against F. necrophorum |
| 03/11/2004 | US20040047868 Administering probiotic, wherein the probiotic is probiotic bacteria selected from Lactobacillus species, with the proviso that the Lactobacillus species is not Lactobacillus GG for prophylaxis and therapy of endotoxemia |
| 03/11/2004 | US20040047867 Adjuvant composition comprising FHA protein or a fragment of FHA protein in its free form |
| 03/11/2004 | US20040047856 Colorstrum-based composition |
| 03/11/2004 | US20040047851 Treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinase activity which comprises administering to the subject an amount of a zinc sphingomyelinase inhibitors effective to decrease |
| 03/11/2004 | US20040047832 Cosmetic and/or dermopharmaceutical preparations containing leaf extracts of the plant argania spinosa |
| 03/11/2004 | US20040047763 Anti-microbial systems and methods |
| 03/11/2004 | DE10334820A1 Pharmazeutische Zusammensetzungen mit antibiotischer Aktivität Pharmaceutical compositions having antibiotic activity |
| 03/11/2004 | DE10240894A1 Verstärkung der Resorption von Subtanzen über die Haut und Schleimhaut Enhance the absorption of Subtanzen through the skin and mucous membrane |
| 03/11/2004 | DE10240343A1 Peroxynitrit-Umlagerungskatalysatoren Peroxynitrite rearrangement catalysts |
| 03/11/2004 | DE10238257A1 New compounds sorbicillactone A and derivatives, useful as antitumor, antiviral and antiinflammatory agents, obtained e.g. by culturing Penicillium fungi |
| 03/11/2004 | CA2706622A1 Lps activation of phagocytic activity |
| 03/11/2004 | CA2497136A1 Buccal, polar or non-polar spray or capsule containing drugs for treating an infectious disease or cancer |
| 03/11/2004 | CA2497112A1 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract |
| 03/11/2004 | CA2497045A1 Pharmaceutical liposomal compositions containing n. meningitidis derived polypeptides or polynucleotides |
| 03/11/2004 | CA2496550A1 Composition based on triethyl citrate for the treatment of bacterial infections of the skin |
| 03/11/2004 | CA2495914A1 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 03/11/2004 | CA2495833A1 Vaccine against yersinia comprising one or two antibodies, one specific for yersinia pestis f1-antigen and the other one for yersina pestis v-antigen |
| 03/11/2004 | CA2493199A1 Peroxynitrite rearrangement catalysts used for the treatment or prophylaxis of diseases caused by peroxynitrite-mediated reactions |
| 03/10/2004 | EP1396542A2 Novel P-selectin ligand protein |
| 03/10/2004 | EP1396493A1 Heterocyclic compounds |
| 03/10/2004 | EP1396492A1 Prodrug of an ice inhibitor |
| 03/10/2004 | EP1396487A1 Phenylpyridine carbonyl piperazine derivative |
| 03/10/2004 | EP1395684A2 New polynucleotides and polypeptides of the ifnalpha-7 gene |
| 03/10/2004 | EP1395658A2 Nucleic acid and protein sequences of bovine epidermal growth factor |
| 03/10/2004 | EP1395652A2 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 03/10/2004 | EP1395607A2 Respiratory syncytial virus |
| 03/10/2004 | EP1395605A2 Polymeric immunoglobulin fusion proteins that target low-affinity fcgamma receptors |
| 03/10/2004 | EP1395594A1 New benzylaminopyrimidines |
| 03/10/2004 | EP1395592A1 Novel pyridylmethylaminopyrimidines |
| 03/10/2004 | EP1395587A1 Process for the preparation of imipenem |
| 03/10/2004 | EP1395585A1 Antibacterial agents |
| 03/10/2004 | EP1395582A1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 03/10/2004 | EP1395571A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 03/10/2004 | EP1395568A1 4-aminopyrimidine derivatives |
| 03/10/2004 | EP1395566A1 Tricyclic compounds useful as angiotensin ii agonists |
| 03/10/2004 | EP1395561A1 Carbamate and oxamide compounds as inhibitors of cytokine production |
| 03/10/2004 | EP1395559A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395554A1 Substituted carbazoles as inhibitors of spla2 |
| 03/10/2004 | EP1395538A1 Vitamin d analogues |
| 03/10/2004 | EP1395283A2 Heterologous protection induced by immunization with invaplex vaccine |
| 03/10/2004 | EP1395279A2 Use of neublastin polypeptides for treating neuropathic pain |
| 03/10/2004 | EP1395273A1 Targeted delivery of drugs for the treatment of viral infections |
| 03/10/2004 | EP1395271A1 Herbal compositions for the treatment of mucosal lesions |
| 03/10/2004 | EP1395270A1 Use of phyllanthus constituents for treating or preventing infections caused by hepatit |
| 03/10/2004 | EP1395269A1 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria |
| 03/10/2004 | EP1395266A1 Antiviral nucleoside derivatives |
| 03/10/2004 | EP1395265A2 Combretastatin a-3 prodrug |
| 03/10/2004 | EP1395262A2 Nucleoside vaccine adjuvants |
| 03/10/2004 | EP1395249A1 Soft elastic capsules comprising ritonavir and/or lopinavir |
| 03/10/2004 | EP1395215A1 Quinolone carboxylic acid compositions and related methods of treatment |
| 03/10/2004 | EP1395127A1 Health feed |
| 03/10/2004 | EP1303249B1 Antimycotic nail varnish composition |
| 03/10/2004 | EP1274713B1 Anti-viral pyrimidine nucleoside analogues |
| 03/10/2004 | EP1234043B1 Constructs for delivery of therapeutic agents to neuronal cells |
| 03/10/2004 | EP1216256B1 Macrolide antibiotics and treatment of pasteurellosis |
| 03/10/2004 | EP1121348B1 Azadioxacycloalkene derivatives, methods for the production thereof and their use as fungicides and pest control agents |
| 03/10/2004 | EP1071693B1 Novel crystalline forms of an antiviral benzimidazole compound |
| 03/10/2004 | EP0854729B1 Improved methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines |
| 03/10/2004 | EP0762894B1 Method of inducing an immune response with a live venezuelan equine encephalitis virus expressing a heterologous immunogen |